Alain Micaleff

Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases.

Dominique Larrey, Thierry Vial, Alain Micaleff et al. · Gut · 1992 · 189 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17

Hepatic Reactions During Treatment of Multiple Sclerosis with Interferon-??-1a

Gordon Francis, Yves Grumser, Enrica Alteri et al. · Drug Safety · 2003 · 97 citations

Life Sciences, Immunology, Neurology +13

Recommendations for benefit–risk assessment methodologies and visual representations

Diana Hughes, Ed Waddingham, Shahrul Mt‐Isa et al. · Pharmacoepidemiology and Drug Safety · 2016 · 70 citations · Full text

Pharmacy, Visualization, Decision Analysis +16

Benefit–risk assessment in a post‐market setting: a case study integrating real‐life experience into benefit–risk methodology

Christine E. Hallgreen, Hendrika A. van den Ham, Shahrul Mt‐Isa et al. · Pharmacoepidemiology and Drug Safety · 2014 · 21 citations

Pharmacy, Decision Sciences, Pharmacotherapy +17

IMI-PROTECT benefit-risk grouprecommendations report:recommendations for the methodology andvisualisation techniques to be used in theassessment of benefit and risk of medicines

Diana Hughes, Ed Waddingham, Shahrul Mt‐Isa et al. · London School of Economics and Political Science Research Online (London School of Economics and Political Science) · 2014 · 15 citations

Pharmacy, Pharmaceutical Policy, Pharmacotherapy +14